It’s the first time in economic history that a growing, multi-billion market has no big, multinational players.
By David Downs / AlterNet
Friday afternoon in a cozy, hip bar in downtown Oakland, California called Cafe Van Kleef, and I’m sitting across the table from the frizzy-haired, denim-jacket-clad blogger for StuffStonersLike.com. He’s sliding a glimmering, dark, cigar-looking package across the table as a big smile breaks out across his face.
“Is this it? This is awesome!” he exclaims, holding up the Schedule 1 illegal drug.
None of the happy hour crowd or the bartenders seem to care. This is Oakland — among the most progressive cities in America, where marijuana is officially the “lowest enforcement priority” for the police.
StuffStonersLike’s founder has a medical cannabis doctor’s recommendation, there are pot clubs down the street, and even though pre-rolled joints are literally given away for free in the San Francisco Bay Area, he’s mesmerized. The office workers enjoying cocktails don’t bat nary an eyelash.
Call it ‘the Cohiba of chronic’. Or, ‘the seventeen dollar doobie.’ This spring, celebrity pot professor Ed Rosenthal brings to market the Ed Rosenthal Select Sativa Medi-Cone — an elegantly packaged, $17 marijuana cigarette that’s destined to give weed heads a major buzz and legalization’s critics fits. [Read more…]











